In the present trial , there was a significant improvement in PFS associated with CIFX , however , its impact on the patient's sense of well-being was not assessed .
The result was impressive , but the importance of bleomycin was unclear and its toxicity sometimes troublesome , so we proposed to compare cisplatin alone versus a regimen of cisplatinplus mitolactol (C + M) and a regimen of cisplatin plusifosfamide (and mesna) (CIFX) .
